Because our present data showed no changes in Cbl‐b and c‐Cbl mRNA in TRAIL‐sensitive and TRAIL‐resistant gastric cancer cells, we performed Affymetrix miRNA chip analyses to identify potential miRNA. The gene discussed is CBLB; the disease is gastric cancer.